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1Common Carp Pituitary Clinical Field Trials - INAD 8391
Year 2008 Annual Summary Report on the Use of 
Common Carp Pituitary in Field Efficacy Trials
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Summary
Spawning aids such as common carp pituitary (CCP), luteinizing hormone-
releasing hormone analogue, and human chorionic gonadotropin are routinely used in
fisheries programs to induce gamete maturation in fish to enhance fish propagation
programs.  The U.S. Food and Drug Administration has authorized the use of CCP
under the Compassionate Investigational New Animal Drug (INAD) Exemption #8391 for
the purpose of gathering efficacy data to support a new animal drug approval for CCP. 
During calendar year 2008 (CY08), 16 INAD trials were conducted to evaluate the
efficacy of CCP to induce gamete maturation in a variety of fish species.  Trials involved
3,738 treated fish and were conducted at eight different fish hatcheries, including six
state hatcheries and two private hatcheries.  Efficacy was determined by whether or not
treated fish (1) produced or yielded eggs or milt, or (2) produced or yielded more eggs
or milt than untreated fish.  Overall results of trials conducted during this period
2indicated that approximately 88% of the trials appeared efficacious, ineffective in 6% of
the trials, and were characterized as inconclusive in 6% of the trials.
Introduction
The use of hormones to induce spawning in fish is critical to the success of many
federal, state, private, and tribal fisheries programs.  A wide variety of programs,
including several that involve the restoration of threatened/endangered species are
dependent upon hormone treatment to complete final gamete maturation and ensure
successful spawning.  
The time of spawning is by its own nature a stressful period for all fish species. 
The handling required during the artificial spawning of fish complicates an already
delicate situation.  In order to maintain the health of both wild and domestic brood fish, it
is beneficial to minimize overall fish handling.  Successful hormone treatment can
reduce handling requirements to a single hormone administration event followed by
actual gamete collection, thereby greatly reducing overall fish handling. 
Studies have shown that final gamete maturation in fish can be induced by the
administration of a variety of hormones (Donaldson and Hunter 1983; Goetz 1983). The
first reported studies investigating the hormonal control of reproduction in fish utilized
intraperitoneal injection of freshly dissected pituitary glands (Houssay, 1931; von
Ihering, 1937).  The use of CCP was first reported in the United States by Hasler et al.,
3(1939, 1940).  These and many other early studies investigating the use of fish
pituitaries to induce gamete maturation in a variety of fish species were thoroughly
reviewed by Pickford and Atz (1957) in their comprehensive treatise on the fish pituitary
gland.  
The efficacy of common carp pituitary (CCP) to induce ovulation and spermiation
in fish is well documented (Chaudhuri, 1976),  CCP has been shown to induce gamete
maturation in a wide variety of species, including certain threatened and endangered
species.  Common carp pituitary, which has been shown to be particularly effective
when used in cool and warm water species, has had a significant, positive impact on
federal, state, private, and tribal programs nationwide.
Purpose
The purpose of this report is to summarize the results of CY08 supplemental
CCP field efficacy trials.  Furthermore, it is expected that these data will be used to
enhance the existing CCP database that has been established from previous years
trials for the purpose of supporting a new animal drug approval for the use of CCP in
aquaculture.
4Facilities, Materials, and Methods
1.  Participating Facilities
A total of 16 trials were conducted at eight fish culture facilities during CY08,
including six state fish hatcheries and two private fish hatcheries.  Water
temperature during treatments at the various testing facilities ranged from 47.5 -
78.0 EF.  Overall mean treatment temperature from all trials was 64.7 EF.
2.  CCP used in trials
All CCP used in CY08 trials was supplied either by Stoller Fisheries, Spirit Lake,
IA; or by Argent Chemical Company, Redmond, WA.
3.  Drug dosages
As described in the current authorization, Investigators were allowed to use CCP
at doses ranging up to 25 mg CCP/kg body weight (bw).  During this reporting
period, the drug doses used ranged from 2.0 to 25.0 mg CCP/kg bw.  CCP was
administered as either a single intraperitoneal (IP) injection, or as a series of two
IP injections. 
Fish Species and Gender Treated
 
1.  Species of fish treated
5The following six fish species were treated with CCP during the reporting period:
Atlantic sturgeon (Acipenser oxyrhynchus)
channel catfish (Ictalurus punctatus)
grass carp (Ctenopharyngodon idella)
muskellunge (Esox masquinongy)
plains minnow (Hybognathus placitus)
suckermouth minnow (Phenacobius mirabilis)
2.  Gender of fish treated
A total of 3,635 females and 103 males were injected with CCP during the
reporting period.   Typically, females are treated with spawning hormones to
shorten the egg maturation period or synchronize ovulation.  Males are treated to
ensure that sufficient milt is available for egg fertilization. 
Data Collected
1.  Pathologists Reports
Fish health pathology reports provide essential information with respect to
disease confirmation and general fish health; no pathology reports were
submitted for CY08.
62.  Primary response variables
The primary response variables for evaluating the effect of CCP were (1) the
relative number of female fish that ovulated following treatment, or (2) the
number of male fish that reached active spermiation following treatment.  With
respect to the treatment of females, in some cases, percent hatch and percent
eyed eggs were also determined.
3.  Spawning interval
The spawning interval is the period of time between the final CCP treatment and
when treated fish were evaluated for gamete maturation.  Where appropriate, the
spawning interval was documented. 
Discussion of Study Results
1. Summary results on the efficacy of CCP to induce gamete maturation (Note:
Summary of CY08 CCP efficacy results are listed in Table 1; Table 2 describes the
number of trials conducted, fish species and number of fish treated, and treatment
regimens used; and Table 3 describes individual CCP trials conducted at all state
and private hatcheries under this INAD).
7A. Efficacy at 2.0 - 2.2 mg/kg bw
Three trials were conducted in which male muskellunge and grass carp
were injected with CCP at a dose of 2.0 or 2.2 mg/kg bw (Table 1). 
Following treatment, there was 100% spermiation among all treated grass
carp, while there was an 89% spermiation among the muskellunge; no
control fish were used.  Overall, treatments appeared efficacious in all
trials. 
B. Efficacy at 4.0 mg/kg bw
Three trials were conducted in which female grass carp and Atlantic
sturgeon were injected with CCP at a dose of 4.0 mg/kg bw (Table 1). 
Following treatment, there was 83 - 88% ovulation among treated grass
carp, while no ovulation occurred in the Atlantic sturgeon; no control fish
were used.  Overall, treatment appeared efficacious in two trials and
ineffective in one trial.
One trial was conducted in which male Atlantic sturgeon were injected
with CCP at a dose of 4.0 mg/kg bw (Table 1).  Following treatment, there
was a 23% spermiation among all treated Atlantic sturgeon; no control fish
were used.  Overall, treatment appeared to be efficacious. 
8C. Efficacy at 6.6 mg/kg bw
Three trials were conducted in which female muskellunge were injected
with CCP at a dose of 6.6 mg/kg bw (Table 1).  One trial involved the use
of a non-treated control group.  Following treatment, there was 25 - 100%
ovulation among treated females.  The control fish did not ovulate. 
Overall, treatment appeared efficacious in two trials and was
characterized as inconclusive in one trial.
D.  Efficacy at 10 mg/kg bw
Two trials were conducted in which female channel catfish were injected
with CCP at a dose of 10 mg/kg bw (Table 1).  Following treatment, there
was 9 - 100% ovulation among treated fish; no control fish were used. 
Overall, treatment appeared efficacious in both trials. 
E. Efficacy at 25 mg/kg bw
Two trials were conducted in which female plains minnow and
suckermouth minnow were injected with CCP at a dose of 25 mg/kg bw
(Table 1).  Following treatment, there was 100% ovulation among treated
females; no control fish were used.  Overall, treatment appeared
efficacious in both trials.
9Two trials were conducted in which male plains minnow and suckermouth
minnow were injected with CCP at a dose of 25 mg/kg bw (Table 1). 
Following treatment, there was 100% among treated fish; no control fish
were used.  Overall, treatment appeared efficacious in both trials. 
2. Observed Toxicity
No toxicity or adverse effects relating to CCP treatment were reported in any of the
trials. 
Current Study Protocol for CCP INAD #8391
Please see the attached current study protocol for CCP INAD #8391. Please note no
changes have occurred to this study protocol.
Facility Sign-up List
Please see “Table 4. Facilities and Names of Investigators” for facilities that signed-
up to participate in the CCP INAD #8391 during CY08.  Facilities not listed in
Appendix III-a of the current CCP INAD #8391 study protocol have been highlighted.
Correspondence sent to CCP Participants
Please see the attached correspondence that was sent to all CCP participants after the
AADAP Office received their sign-up form for calendar year 2008.
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Number of Treated Fish under Slaughter Authorization
Total number of treated fish during CY08 was 3,738.  The total number of treated
fish to count against the slaughter authorization dated July 7, 2006 is 9,911.  No
changes have occurred to the current CCP INAD #8391 study protocol. 
Summary of Study Results
The efficacy of CCP was evaluated in 16 trials involving Atlantic sturgeon, channel
catfish, grass carp, muskellunge, plains minnow, and suckermouth minnow treated at
doses ranging from 2.0 to 25 mg/kg bw.  Treatment was administered as either a single
IP injection or as a series of 2 IP injections.  Of the 16 trials conducted, one utilized a
non-treated control group.  A total of 3,738 adult fish were treated (3,635 females and
103 males).  Water temperature during treatment ranged from 47.5 to 78.0EF.  Overall,
results showed that CCP treatment appeared efficacious in 88% of the trials, ineffective
in 6% of the trials, and inconclusive in 6% of the trials.  Investigators reported no
evidence of toxicity or adverse effects related to CCP treatment in any trial.  Because of
the lack of pivotal field efficacy trials, it is understood that data summarized in this report
can only be considered as ancillary data.  None-the-less, the ancillary data described
above should provide useful corroborative data to support a new animal drug approval
for CCP.  It is anticipated that additional ancillary efficacy data will continue to be
collected under INAD #8391.  In future trials conducted under INAD #8391, efforts will
be directed towards the continued generation of high quality data.
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Table 1.  Summary of CY08 CCP Efficacy Results Females Males
Treated Control Treated Control
Apparent
Efficacy
Number
of Trials
Facility Species Treatment
Method
Dose
(mg/kg)
Spawning
Interval
Number
Treated
% Ovulate Number
Controls
% Ovulate Number
Treated
%
Spermiate
Number
Controls
%
Spermiate
Efficacious 1 Manning SFH Atlantic
Sturgeon
Injection 4 24 hr 0 na 0 na 13 23 0 na
Ineffective 1 Manning SFH Atlantic
Sturgeon
Injection 4 24 hr 1 0 0 na 0 na 0 na
Efficacious 1 Baxter Land
Co.
Channel
Catfish
Injection 10 24 - 26 hr 2,677 9 - 90 0 na 0 na 0 na
Efficacious 1 NeedMore
Fisheries
Channel
Catfish
Injection 10 28 hr 813 43 - 100 0 na 0 na 0 na
Efficacious 2 E.W. Shell
Fisheries
Center
Grass Carp Injection 4 10 -11 hrs 14 83 - 88 0 na 0 na 0 na
Efficacious 2 E.W. Shell
Fisheries
Center
Grass Carp Injection 2 8 - 9 hr 0 na 0 na 9 100 0 na
Efficacious 1 Hackettstown
SFH
Musky Injection 6.6 6 days 16  50 - 100 1 0 0 na 0 na
Efficacious 1 Table Rock
SFH
Musky Injection 6.6 4 days 6 66 0 na 0 na 0 na
Efficacious 1 Table Rock
SFH
Musky Injection 2.2 4 days 0 na 0 na 9 89 0 na
Inconclusive 1 West Metro
Fisheries Area
Office
Musky Injection 6.6 48 hrs 4 25 0 na 0 na 0 na
Efficacious 2 Native Aquatic
Species
Restoration
Facility
Plains Minnow Injection 25 12 hrs 91 100 0 na 53  100 0 na
Efficacious 2 Suckermouth
Minnow
Injection 25 24 - 72 hrs 13 100 0 na 19 100 0 na
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Table 2. Description of number of trials conducted, species and
number of fish treated, and treatment regimens used in
CY08 under INAD #8391
_________________________________________________________
Total Number of Trials Conducted: 16
Number of Efficacious Trials: 14
Number of Ineffective Trials:   1
Number of Inconclusive Trials:   1
Total Number of Fish Treated:           3,738
Treatment Regimes Used:
       2.0 - 2.2 mg/kg body weight (1 injection)      3 trials
4.0 mg/kg body weight (1 - 2 injections)      4 trials
6.6 mg/kg body weight (1 injection)      3 trials
     10.0 mg/kg body weight (2 injections)      2 trials
25.0 mg/kg body weight (1 injection)      4 trials
Treatment Water Temperature (oF):                      47.5 - 78.0
Size of Treated Fish:         Adult
Species Treated:   Atlantic sturgeon (Acipenser oxyrhynchus)
channel catfish (Ictalurus punctatus)
grass carp (Ctenopharyngodon idella)
muskellunge Esox masquinongy
plains minnow Hybognathus placitus
suckermouth minnow Phenacobius mirabilis
_________________________________________________________
